Recombinant Human UGT2B17 Protein ，His

UGT2B17, a member of the UDP-glucuronosyltransferase enzyme family, plays a critical role in the metabolism of various endogenous and exogenous compounds, including drugs, hormones, and environmental toxins, through glucuronidation, a process that enhances their solubility and facilitates excretion. The importance of UGT2B17 in pharmacogenomics is underscored by its genetic variability, which can lead to significant interindividual differences in drug metabolism and response. Research has indicated that certain polymorphisms in the UGT2B17 gene can result in either reduced or enhanced enzymatic activity, thereby influencing the pharmacokinetics of drugs metabolized by this enzyme, such as opioids and antihistamines. Understanding the structure-function relationship of UGT2B17 through the study of its recombinant protein is vital for elucidating its enzymatic mechanisms and potential as a therapeutic target. Moreover, UGT2B17's involvement in the metabolism of steroid hormones, particularly androgens, underscores its relevance in conditions like prostate cancer and other endocrine disorders. Consequently, the recombinant expression and characterization of UGT2B17 can provide insights into its functional properties and aid in the development of personalized medicine strategies, ultimately improving therapeutic outcomes for individuals based on their genetic makeup. Given the implications of UGT2B17 in drug interactions and disease pathogenesis, ongoing research focuses on its functional variants, substrate specificity, and regulatory mechanisms to pave the way for improved disease management and drug development.